Latest News and Press Releases

CHALFONT, Pa., March 18, 2013 (GLOBE NEWSWIRE) -- Genomind, a personalized medicine company, was awarded "Best in Class" for their Genecept™ Assay microsite, geneceptassay.com, during the 2013...

WASHINGTON, March 11, 2013 (GLOBE NEWSWIRE) -- Genomind, a personalized medicine company, is pleased to announce their participation at the National Association of Psychiatric Health Systems Annual...

LAS VEGAS, Feb. 12, 2013 (GLOBE NEWSWIRE) -- Genomind, a personalized medicine company, is pleased to embark on a solid week of education and promotion of the Genecept™ Assay. This week,...

CHALFONT, Pa., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Genomind, a personalized medicine company for neuropsychiatry, is excited to announce that company representatives will be attending and exhibiting at...

SAN DIEGO, Oct. 18, 2012 (GLOBE NEWSWIRE) -- Genomind, a personalized medicine company for neuropsychiatry, is excited to announce its new clinician online portal at the Neuroscience Education...

CHALFONT, Pa., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Genomind is pleased to announce that on October 9 and 10, 2012, they will host a complimentary educational webinar featuring Dr. Jay Lombard, Chief...

WASHINGTON, Sept. 13, 2012 (GLOBE NEWSWIRE) -- Genomind, LLC, a neuropsychiatric personalized medicine company, recently announced the addition of a new member to its leading Scientific Advisory...